{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-25-000031","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2025-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.179716+00:00","generated_at":"2026-05-18T04:42:15.781865+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Tenet Q2 adjusted EPS $4.02 (+74% YoY); raises FY 2025 EBITDA outlook to $4.40-$4.54B","bullets":["Q2 2025 net income $288M, $3.14 diluted EPS; adjusted diluted EPS $4.02 vs $2.31 in Q2 2024.","Consolidated Adj. EBITDA $1.121B (+18.6% YoY); margin 21.3%. Ambulatory Care Adj. EBITDA $498M (+11.4%).","Board authorized $1.5B increase to share repurchase program, leaving $1.781B remaining as of July 22.","FY 2025 Adj. EBITDA outlook raised to $4.40-$4.54B (midpoint +$395M vs prior). Free cash flow guide $2.025-$2.275B.","H1 2025 free cash flow $1.385B vs $948M in H1 2024; net debt/Adj. EBITDA 2.45x."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-25-000031","json":"https://secwatch.observer/filing/0000070318-25-000031.json","markdown":"https://secwatch.observer/filing/0000070318-25-000031.md","text":"https://secwatch.observer/filing/0000070318-25-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031825000031/0000070318-25-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031825000031/thc-20250722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:42:15.781865+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}